Tulopafant structure
|
Common Name | Tulopafant | ||
---|---|---|---|---|
CAS Number | 116289-53-3 | Molecular Weight | 425.50200 | |
Density | 1.32g/cm3 | Boiling Point | 613.3ºC at 760mmHg | |
Molecular Formula | C25H19N3O2S | Melting Point | N/A | |
MSDS | N/A | Flash Point | 324.7ºC |
Use of TulopafantTulopafant is a platelet activating factor (PAF) antagonist. |
Name | N-(3-benzoylphenyl)-3-pyridin-3-yl-1,3-dihydropyrrolo[1,2-c][1,3]thiazole-7-carboxamide |
---|---|
Synonym | More Synonyms |
Description | Tulopafant is a platelet activating factor (PAF) antagonist. |
---|---|
Related Catalog | |
In Vitro | Preincubation of neutrophils with Tulopafant (RP 59227) results in a concentration-dependent decrease in chemiluminescence produced by PAF primed cells[1]. |
In Vivo | Tulopafant (RP 59227) effectively reduces myocardial infarct size and reduces the incidence of ischemia and reperfusion-induced arrhythmias in barbital-anesthetized dogs[1].Histological examination reveals marked diminution of both interstitial hemorrhage and deposition of platelet and granulocytes in capillaries of cardiac xenografts when recipient animals are pretreated with Tulopafant[2]. |
References |
Density | 1.32g/cm3 |
---|---|
Boiling Point | 613.3ºC at 760mmHg |
Molecular Formula | C25H19N3O2S |
Molecular Weight | 425.50200 |
Flash Point | 324.7ºC |
Exact Mass | 425.12000 |
PSA | 89.29000 |
LogP | 5.23310 |
Vapour Pressure | 5.63E-15mmHg at 25°C |
Index of Refraction | 1.702 |
Storage condition | 2-8℃ |
Tulopafant |
Tulopafantum |
UNII-IQ3Q8N1287 |